Category: COVID-19

The vaccine rush has left Johnson and Johnson grasping for air.. Pfizer’s profits have been wide.. In just the first four months of vaccines being administered, the company reportedly earned $3.5 billion with a B .. it is expected to have close to $30 bil in profits in 2021!

The roaring 20s for the roarings Pharms..

Meanwhile Pfizer will be heading to the federal government to get full final approval of its arm jabs, with the goal in mind of having the age 2 to 12 bracket in getting vaccinated in September for the 21/22 school year.

Pfizer is the first coronavirus vaccine maker in the U.S. to request full approval. Like Pfizer, the Moderna and Johnson & Johnson vaccines had been previously cleared for use under the agency’s emergency use authorization — a less rigorous approval method to aid a swifter response to the pandemic.

An FDA approval for a vaccine means the agency has decided that its benefits outweigh the known risks following a review of the manufacturer’s testing results.

If granted, Pfizer’s full stamp of approval would only apply to the vaccine for people who are 16 and older. Meanwhile, the vaccine maker is seeking emergency use authorization for its COVID-19 vaccine to include children between 12 and 15.

x x x

The kids aren’t alright

Pfizer said it will seek emergency authorization for the COVID vaccine for kids ages 2-11 in September, The New York Times reported .. The news comes as the the FDA is expected to authorize the Pfizer vaccine for kids 12-15 in the next week, sources have said. In March, the pharmaceutical giant began testing the vaccine on kids aged 6 months to 11 years old.

x x x

MANDATE

The other implication, Dr. Avula said, was possible governmental mandating of the vaccine. “When we’ve tackled this question over the last few months, it wasn’t even a consideration because the government couldn’t mandate a vaccine that was under EUA, Emergency Use Authorization. Now that we, you know, may be seeing this move to full licensure in a few months — that does open up the possibility,” said Dr. Avula.

DEVELOPING

A few headlines to set this up:

Vaccinations slowing as supply outstrips demand…

Many police officers spurn as departments avoid mandates…

Iowa turns down 71% of available jabs…

….it would seem that despite the rosy scenario of 100 million doses being administered across the United States, there has been a suddenly decline of enthusiasm for getting the shot.. Or shots.

Why?

Perhaps the answers can be assumed after seeing one graphical representation of usage across the United States.

It would appear that when the Johnson & Johnson pause occurred because of blood clots, all vaccines went down. With the complete tanking of the J&J it would appear that no one knows the pause has been un-paused again…

For your discernment and review:

The power of the press!!
It is still a real thing regardless of who thinks what is ‘fake news’..

The New York TIMES generated some chatter on the Internets for a report that ‘herd immunity’ may not occur in the United States..

Though American cases have yet again been falling, perhaps that seasonal spring sun has worked to get people in fresh air again.. also 100 million vaccines have been administered in the United States. The rest of the world has seen a surge of the scourge, but to date North America has been watching a reprieve in the hell.

Apoorva Mandavilli writes this in the TIMES:

Early in the pandemic, when vaccines for the coronavirus were still just a glimmer on the horizon, the term “herd immunity” came to signify the endgame: the point when enough Americans would be protected from the virus so we could be rid of the pathogen and reclaim our lives. Now, more than half of adults in the United States have been inoculated with at least one dose of a vaccine. But daily vaccination rates are slipping, and there is widespread consensus among scientists and public health experts that the herd immunity threshold is not attainable — at least not in the foreseeable future, and perhaps not ever. Instead, they are coming to the conclusion that rather than making a long-promised exit, the virus will most likely become a manageable threat that will continue to circulate in the United States for years to come, still causing hospitalizations and deaths but in much smaller numbers.

The TIMES article focuses on the dwindling vaccination rates, and the variants. Mandavilla writes, “It is already clear, however, that the virus is changing too quickly, new variants are spreading too easily and vaccination is proceeding too slowly for herd immunity to be within reach anytime soon.”

x x x

The world deserves truth and now fanciful lies and feel good ”flatten the curve” style phrases. People need to realize that this virus will undoubtedly now stay in circulation for the foreseeable future. It will not go away.. with time and medical intervention, there will be a lessening degree of severity. But it should never be assumed that this can be eradicated 100% ..

That said, some of the perilous stories about vaccine compliance dropping forgets one more thing: Natural immunity .. there are some estimate that up to 1/3 of Americans already had COVID at some point during the previous year..

That adds to the notion of ‘herd’ immunity.

However, there is one more thing to consider: The question of how long immunity will last.

We have seen stories of vaccinated people getting COVID. Or those who had the virus getting it again.. Even some stories from other nations have dropped stating that people get TWO COVIDS (two variants) at one time!

x x x

It is fascinating to consider the ‘flatten the curve’ stay at home world of 2020.. This from the TIMES:

Once the novel coronavirus began to spread across the globe in early 2020, it became increasingly clear that the only way out of the pandemic would be for so many people to gain immunity — whether through natural infection or vaccination — that the virus would run out of people to infect. The concept of reaching herd immunity became the implicit goal in many countries, including the United States.

DEVELOPING..